The Effect of Decreased Uterine Filling Pressure in Hysteroscopy, a Double-blind Control Trial
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 35
- 试验地点
- 2
- 主要终点
- Procedure Time
研究概览
简要总结
The aim of the study is to compare the outcomes of patients undergoing hysteroscopy with a Myosure device with a pressure of 60 mmHg to those using the standard of 80 mmHg.
详细描述
An a priori sample size calculation was completed. To achieve 80% power and an alpha of .05, the study team needed a sample size of 68 total with 34 participants in each group.The study will be a double-blind randomized control trial. Patients will be recruited based on surgery type (hysteroscopy) and consented using a written consent by the research coordinator with sufficient time to ensure patient comprehension and allow for any questions. The consent process will happen in the pre-operative appointment. Participants will then be randomized to either the standard of care of 80mmHg or the experimental pressure of 60 mmHg for uterine filling pressure via an automated randomization program. The physician performing the surgery and the patient will not know what group they are assigned to. The procedure involved in the study will be hysteroscopy. Hysteroscopy is a procedure that is used to diagnose and sometimes treat intrauterine pathologies. In order to visualize the uterus, pressurized saline is used to distend the uterus.
In this study, the specific hysteroscopic procedure will involve the removal of uterine fibroids with a MyoSure Hysteroscopic Morcellator device. These tissue samples will be collected and sent to Pathology to be weighed. During the surgery, the surgeon will be able to request an adjustment pressure if visualization is not adequate. Physicians will start with a pressure of 80mmHg. Once physician is ready to introduce the myosure hysteroscopy device, the pressure level will then be randomized. During the procedure, monitoring will be done by anesthesia through the use of pulse oximetry and measurement of vitals during the Monitored Anesthesia Care. There is also real-time monitoring of hysteroscopic fluid deficit via the fluid management system that is attached to the hysteroscopic pump. Fluid deficit can also be confirmed by the nurse who manually counts the amount of fluid used during theprocedure. Per policy, once a 2500mL deficit is reached, the procedure is terminated. After the surgery, the surgeon will fill out a questionnaire that measures the outcomes of surgeon satisfaction and visualization during the procedure. The other end points of procedure time, specimen weight, volume of normal saline used, any changes in pressure needed during the surgery, and whether the patient required Lasix post-operatively will also be collected at this time.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- Double (Care Provider, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Patients electing for operative or diagnostic hysteroscopy procedures for management of polyps and fibroids
- •Age equal to or greater than 18
- •Ability to understand and willingness to sign consent form. We will include non-English speaking patients in this study
排除标准
- •Patients electing for operative and diagnostic hysteroscopy procedures with polyps and fibroids
- •Patients under the age of 18
研究组 & 干预措施
60 mmHg MyoSure Hysteroscopic Morcellator Device
The rationale for this experimental arm is that the pressurization can result in excess fluid being absorbed by the patient without a substantial benefit to surgical outcome. Minimizing the pressure from 80 mmHg (which is standard of care) to 60 mmHg used during this procedure may optimize outcome without compromising visualization of the surgeon. The research procedure will take place in the operating room of the minimally invasive gynecologic surgery department.
干预措施: MyoSure Hysteroscopic Morcellator Device (Device)
80 mmHg MyoSure Hysteroscopic Morcellator Device
This is the standard of care pressurization for this procedure at Northwestern Medicine and will be the control group for the study
干预措施: MyoSure Hysteroscopic Morcellator Device (Device)
结局指标
主要结局
Procedure Time
时间窗: Through study completion, an average of 1 year
Duration of surgery to assess if pressure changes affects length of surgery time.
Physician Survey to assess visualization
时间窗: Through study completion, an average of 1 year
Determining whether lowering pressure on hysteroscopic morcellator during hysteroscopy, using block randomization, affects visualization for surgeon using a post-op survey for surgeon to gauge outcomes.
Lasix administered post-operatively
时间窗: Through study completion, an average of 1 year
Noting yes or no if Lasix was administered post-operatively.
Specimen Weight
时间窗: Through study completion, an average of 1 year
Specimen will be sent to pathology to note weight in grams.
Amount of Fluid
时间窗: Through study completion, an average of 1 year
Volume of normal saline used during procedure.
Change in pressure was needed
时间窗: Through study completion, an average of 1 year
Noting if pressure needed changing by surgeon during the procedure.
次要结局
未报告次要终点
研究者
Magdy Milad, MD
Professor of Obstetrics and Gynecology
Northwestern University
